Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;29(7):1415-1419.
doi: 10.3201/eid2907.230216.

Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020

Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020

Theodore K Marras et al. Emerg Infect Dis. 2023 Jul.

Abstract

We measured annual prevalence of microbiologically defined nontuberculous mycobacterial lung disease in Ontario, Canada. Mycobacterium avium prevalence was 13 cases/100,000 persons in 2020, a 2.5-fold increase from 2010, indicating a large increase in true M. avium lung disease. During the same period, M. xenopi decreased nearly 50%, to 0.84 cases/100,000 persons.

Keywords: Canada; Mycobacterium avium-intracellulare complex; Mycobacterium intracellulare; Ontario; atypical mycobacteria; bacteria; epidemiology; mycobacteria; nontuberculous mycobacteria; prevalence; pulmonary nontuberculous mycobacteria; respiratory infections; tuberculosis and other mycobacteria.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Categories of nontuberculous mycobacteria pulmonary disease, Ontario, Canada, 2020. A) Uncertain state: 1 sputum culture. B) Standard microbiological criteria: >2 sputum cultures with the same species, or 1 bronchoscopic or lung biopsy culture. C) Strict microbiological criteria (subset of standard): >3 sputum cultures with the same species, or >2 bronchoscopic cultures with the same species, or 1 bronchoscopic plus 1 sputum culture with the same species, or 1 lung biopsy culture. Some images were obtained from Flaticon (https://www.flaticon.com).
Figure 2
Figure 2
Prevalence of nontuberculous mycobacterial pulmonary disease (standard definition) by Ontario health region, Ontario, Canada, 2020. Numbers below region names indicate number of cases per 100,000 population.

References

    1. Daley CL, Iaccarino JM Jr, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56:2000535. 10.1183/13993003.00535-2020 - DOI - PMC - PubMed
    1. Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36:13–34. 10.1016/j.ccm.2014.10.002 - DOI - PMC - PubMed
    1. Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis. 2013;19:1889–91. 10.3201/eid1911.130737 - DOI - PMC - PubMed
    1. Heffer MJ, Al-Ghimlas F, Hoffstein V, Jamieson FB, Mehta M, Chedore P, et al. Mycobacterium avium and Mycobacterium intracellulare: distinct pathogens or just a “complex”? In: Abstracts of the American Thoracic Society 2010 International Conference: New Orleans, Louisiana, May 14‒19, 2010. Am J Respir Crit Care Med. 2010;181:A2608.
    1. Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008‒2015. Ann Am Thorac Soc. 2020;17:178–85. 10.1513/AnnalsATS.201804-236OC - DOI - PMC - PubMed

MeSH terms